Solta Medical Inc. (SLTM)

2.92
0.00 (0.00)
Prev Close 2.92
Open 2.92
Day Low/High 2.92 / 2.93
52 Wk Low/High 1.44 / 2.99
Volume 1.01M
Avg Volume 1.53M
Exchange
Shares Outstanding 81.53M
Market Cap 238.06M
EPS -0.59
Div & Yield N.A. (N.A)

Latest News

SHAREHOLDER ALERT: Law Office Of Brodsky & Smith, LLC Announces Investigation Of Solta Medical, Inc.

SHAREHOLDER ALERT: Law Office Of Brodsky & Smith, LLC Announces Investigation Of Solta Medical, Inc.

Law office of Brodsky & Smith, LLC announces that it is investigating potential claims against the Board of Directors of Solta Medical, Ltd.

SOLTA MEDICAL INVESTOR ALERT: Faruqi & Faruqi, LLP Announces The Investigation Of Solta Medical, Inc. (SLTM) Over The Proposed Sale Of The Company To Valeant Pharmaceuticals (VRX)

SOLTA MEDICAL INVESTOR ALERT: Faruqi & Faruqi, LLP Announces The Investigation Of Solta Medical, Inc. (SLTM) Over The Proposed Sale Of The Company To Valeant Pharmaceuticals (VRX)

Juan E. Monteverde, a partner at Faruqi & Faruqi, LLP, a leading national securities firm headquartered in New York City, is investigating the Board of Directors of Solta Medical, Inc.

Law Firm Kirby McInerney LLP Investigating Potential Claims On Behalf Of Solta Medical, Inc. Stockholders

Law Firm Kirby McInerney LLP Investigating Potential Claims On Behalf Of Solta Medical, Inc. Stockholders

Kirby McInerney LLP is investigating potential claims against the Board of Directors of Solta Medical, Inc.

Finkelstein Thompson LLP Investigates Potentially Unfair Buyout Of Solta Medical, Inc.

Finkelstein Thompson LLP Investigates Potentially Unfair Buyout Of Solta Medical, Inc.

The law firm of Finkelstein Thompson LLP is investigating potential claims on behalf of shareholders of Solta Medical, Inc.

Valeant (VRX) To Buy Solta Medical (SLTM) For $236 Million in Cash

Valeant (VRX) To Buy Solta Medical (SLTM) For $236 Million in Cash

Valeant Pharmaceuticals (VRX) will buy Solta Medical (SLTM) for $2.92 per share in cash.

SOLTA MEDICAL INVESTOR ALERT: Faruqi & Faruqi, LLP Announces The Investigation Of Solta Medical, Inc. (SLTM) Over The Proposed Sale Of The Company To Valeant Pharmaceuticals (VRX)

SOLTA MEDICAL INVESTOR ALERT: Faruqi & Faruqi, LLP Announces The Investigation Of Solta Medical, Inc. (SLTM) Over The Proposed Sale Of The Company To Valeant Pharmaceuticals (VRX)

Juan E. Monteverde, a partner at Faruqi & Faruqi, LLP, a leading national securities firm headquartered in New York City, is investigating the Board of Directors of Solta Medical, Inc.

Solta Medical Shareholder Alert: Former SEC Attorney Willie Briscoe And Powers Taylor LLP Investigate Acquisition By Valeant Pharmaceuticals

Solta Medical Shareholder Alert: Former SEC Attorney Willie Briscoe And Powers Taylor LLP Investigate Acquisition By Valeant Pharmaceuticals

Former United States Securities and Exchange Commission attorney Willie Briscoe and the securities litigation firm of Powers Taylor LLP are investigating potential claims against the Board of Directors of Solta...

4 Health Care Stocks Under $10 to Watch

4 Health Care Stocks Under $10 to Watch

Keep these under-$10 stocks on your radar.

SLTM: Insiders Vs. Shorts

SLTM: Insiders Vs. Shorts

The most recent short interest data was recently released by the NASDAQ for the 09/13/2013 settlement date, and Solta Medical, Inc is one of the most shorted stocks of the Russell 3000, based on 5.97 "days to cover" versus the median component at 5.40. There are a number of ways to look at short data, but one metric that we find particularly useful is the "days to cover" because it considers both the total shares short and the average daily volume of shares typically traded.

Short Interest Declines 22% For SLTM

Short Interest Declines 22% For SLTM

The most recent short interest data has been released by the NASDAQ for the 07/31/2013 settlement date, which shows a 354,989 share decrease in total short interest for Solta Medical, Inc , to 1,266,058, a decrease of 21.90% since 07/15/2013. Total short interest is just one way to look at short data; another metric that we here at Dividend Channel find particularly useful is the "days to cover" metric because it considers both the total shares short and the average daily volume of shares traded.

Solta Medical Appoints Mingo Ku As Vice President Global Sales

Solta Medical Appoints Mingo Ku As Vice President Global Sales

Former Head of International Sales Promoted to Lead Company's Global Sales